ETR:MED Statistics
Total Valuation
ETR:MED has a market cap or net worth of EUR 251.75 million. The enterprise value is 542.56 million.
| Market Cap | 251.75M |
| Enterprise Value | 542.56M |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
ETR:MED has 47.50 million shares outstanding.
| Current Share Class | 47.50M |
| Shares Outstanding | 47.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.68% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 36.24% |
| Float | 11.44M |
Valuation Ratios
The trailing PE ratio is 8.11 and the forward PE ratio is 6.63.
| PE Ratio | 8.11 |
| Forward PE | 6.63 |
| PS Ratio | 0.32 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | 4.90 |
| P/OCF Ratio | 2.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.67, with an EV/FCF ratio of 10.35.
| EV / Earnings | 17.78 |
| EV / Sales | 0.67 |
| EV / EBITDA | 4.67 |
| EV / EBIT | 8.61 |
| EV / FCF | 10.35 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 1.36.
| Current Ratio | 1.84 |
| Quick Ratio | 1.17 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | 7.16 |
| Interest Coverage | 3.41 |
Financial Efficiency
Return on equity (ROE) is 11.91% and return on invested capital (ROIC) is 8.76%.
| Return on Equity (ROE) | 11.91% |
| Return on Assets (ROA) | 4.50% |
| Return on Invested Capital (ROIC) | 8.76% |
| Return on Capital Employed (ROCE) | 9.26% |
| Weighted Average Cost of Capital (WACC) | 5.06% |
| Revenue Per Employee | 117,000 |
| Profits Per Employee | 4,402 |
| Employee Count | 7,055 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 109.18 |
Taxes
In the past 12 months, ETR:MED has paid 9.02 million in taxes.
| Income Tax | 9.02M |
| Effective Tax Rate | 22.27% |
Stock Price Statistics
The stock price has increased by +51.43% in the last 52 weeks. The beta is 0.47, so ETR:MED's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +51.43% |
| 50-Day Moving Average | 5.34 |
| 200-Day Moving Average | 4.33 |
| Relative Strength Index (RSI) | 48.81 |
| Average Volume (20 Days) | 6,302 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:MED had revenue of EUR 825.43 million and earned 31.06 million in profits. Earnings per share was 0.65.
| Revenue | 825.43M |
| Gross Profit | 168.05M |
| Operating Income | 64.02M |
| Pretax Income | 40.49M |
| Net Income | 31.06M |
| EBITDA | 88.16M |
| EBIT | 64.02M |
| Earnings Per Share (EPS) | 0.65 |
Balance Sheet
The company has 91.72 million in cash and 381.62 million in debt, with a net cash position of -289.90 million or -6.10 per share.
| Cash & Cash Equivalents | 91.72M |
| Total Debt | 381.62M |
| Net Cash | -289.90M |
| Net Cash Per Share | -6.10 |
| Equity (Book Value) | 280.66M |
| Book Value Per Share | 5.89 |
| Working Capital | 148.08M |
Cash Flow
In the last 12 months, operating cash flow was 97.43 million and capital expenditures -44.10 million, giving a free cash flow of 53.33 million.
| Operating Cash Flow | 97.43M |
| Capital Expenditures | -44.10M |
| Depreciation & Amortization | 24.13M |
| Net Borrowing | -77.84M |
| Free Cash Flow | 53.33M |
| FCF Per Share | 1.12 |
Margins
Gross margin is 20.36%, with operating and profit margins of 7.76% and 3.76%.
| Gross Margin | 20.36% |
| Operating Margin | 7.76% |
| Pretax Margin | 4.91% |
| Profit Margin | 3.76% |
| EBITDA Margin | 10.68% |
| EBIT Margin | 7.76% |
| FCF Margin | 6.46% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 0.75%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 0.75% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.12% |
| FCF Payout Ratio | 3.56% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.73% |
| Earnings Yield | 12.34% |
| FCF Yield | 20.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ETR:MED has an Altman Z-Score of 1.76 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.76 |
| Piotroski F-Score | 6 |